Leidos Holdings, Inc. (NYSE:LDOS) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC trimmed its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 63.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 6,192 shares of the aerospace company’s stock after selling 10,588 shares during the period. SG Americas Securities LLC’s holdings in Leidos were worth $1,009,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. 1832 Asset Management L.P. acquired a new position in Leidos during the second quarter worth $34,000. Blue Trust Inc. boosted its holdings in Leidos by 251.3% in the 2nd quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock worth $41,000 after buying an additional 201 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in Leidos by 122.5% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock worth $45,000 after buying an additional 169 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Leidos during the second quarter valued at approximately $60,000. Finally, Versant Capital Management Inc lifted its position in shares of Leidos by 257.7% in the second quarter. Versant Capital Management Inc now owns 440 shares of the aerospace company’s stock valued at $64,000 after acquiring an additional 317 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Insider Buying and Selling at Leidos

In other Leidos news, Director Robert C. Kovarik, Jr. sold 1,059 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $145.23, for a total value of $153,798.57. Following the transaction, the director now owns 7,455 shares of the company’s stock, valued at $1,082,689.65. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Thomas Arthur Bell bought 1,712 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were purchased at an average cost of $145.04 per share, for a total transaction of $248,308.48. Following the completion of the purchase, the chief executive officer now owns 22,398 shares of the company’s stock, valued at approximately $3,248,605.92. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,059 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $145.23, for a total transaction of $153,798.57. Following the sale, the director now owns 7,455 shares in the company, valued at $1,082,689.65. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

LDOS has been the subject of several recent research reports. Wells Fargo & Company increased their price objective on Leidos from $172.00 to $183.00 and gave the company an “overweight” rating in a research note on Tuesday, October 1st. Truist Financial lifted their target price on shares of Leidos from $165.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, September 5th. JPMorgan Chase & Co. lifted their target price on shares of Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. TD Cowen lifted their target price on shares of Leidos from $155.00 to $166.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Finally, Royal Bank of Canada lifted their target price on shares of Leidos from $140.00 to $145.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 31st. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $166.92.

Leidos Trading Down 1.9 %

Shares of LDOS stock opened at $164.55 on Friday. The company’s 50-day moving average price is $154.55 and its 200-day moving average price is $146.17. Leidos Holdings, Inc. has a twelve month low of $90.30 and a twelve month high of $168.02. The company has a current ratio of 1.21, a quick ratio of 1.11 and a debt-to-equity ratio of 0.91. The stock has a market cap of $22.17 billion, a price-to-earnings ratio of 70.93, a PEG ratio of 1.49 and a beta of 0.70.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, July 30th. The aerospace company reported $2.63 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.36. Leidos had a net margin of 2.72% and a return on equity of 28.40%. The company had revenue of $4.13 billion for the quarter, compared to analysts’ expectations of $4.06 billion. During the same quarter in the prior year, the company posted $1.80 earnings per share. Leidos’s revenue for the quarter was up 7.7% compared to the same quarter last year. As a group, equities analysts predict that Leidos Holdings, Inc. will post 8.95 earnings per share for the current year.

Leidos Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 27th. Shareholders of record on Friday, September 13th were given a $0.38 dividend. The ex-dividend date was Friday, September 13th. This represents a $1.52 dividend on an annualized basis and a yield of 0.92%. Leidos’s payout ratio is currently 65.52%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.